Speakers

Michael Karin

Michael
Karin

University of California - Department of Pharmacology, US
Michael
Karin
Hans  Karten

Hans
Karten

Chief Executive & Technology Officer Genalice, NL
Hans
Karten
Nachiket Kashikar

Nachiket
Kashikar

Head of Business Development, Service, and Commercial Operations, Resolve BioSciences GmbH, DE
Nachiket
Kashikar
Yuki Katanosaka

Yuki
Katanosaka

Department of Molecular Physiology, Okayama University, JP
Yuki
Katanosaka
Manolis Kellis

Manolis
Kellis

MIT Computer Science and Artificial Intelligence Lab; Broad Institute of MIT and Harvard, US
Manolis
Kellis
Rob Kent

Rob
Kent

School of Life Sciences (Centre for Gene Regulation and Expression), University of Dundee, UK
Rob
Kent
Eunjoon Kim

Eunjoon
Kim

IBS/KAIST (Inst Basic Sci/Korea Adv Inst Sci Technol), KR
Eunjoon
Kim
Tae-Wuk  Kim

Tae-Wuk
Kim

Department of Life Science, College of Natural Sciences, Hanyang University, KR
Tae-Wuk
Kim
Clare Kingsley

Clare
Kingsley

Senior Director of the Illumina Laboratory Services, Illumina, UK
Clare
Kingsley
Agnete Kirkeby

Agnete
Kirkeby

Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), University of Copenhagen, DK
Agnete
Kirkeby